Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-08-09 01:12 | 2013-08-06 | PMCS | N/A | RELATIONAL INVESTORS LLC | 10% owner | Other | BUY | $6.49 | 457,969 | $2,973,959 | 21,303,334 | +2.2% |
| 2013-08-09 03:04 | 2013-08-06 | S | N/A | SOFTBANK CORP | 10% owner | Other | BUY | $6.88 | 3,885,360 | $26,714,958 | 3,109,219,095 | +0.1% |
| 2013-08-07 23:09 | 2013-08-06 | AMH | American Homes 4 Rent | Singelyn David P. | Director, Officer, 10% owner - Chief Executive Officer | Real Estate Investment Trusts | BUY | $16.00 | 3,125,000 | $50,000,000 | 6,860,783 | +83.7% |
| 2013-08-07 23:07 | 2013-08-06 | AMH | American Homes 4 Rent | American Homes 4 Rent, LLC | 10% owner | Real Estate Investment Trusts | BUY | $16.00 | 3,125,000 | $50,000,000 | 6,860,783 | +83.7% |
| 2013-08-07 23:29 | 2012-04-01 | AMEH | Astrana Health, Inc. | Augusta Gary | Director | Services-Management Consulting Services | BUY | $100.00 | 100,000 | $10,000,000 | 1,011,600 | +11.0% |
| 2013-08-06 22:45 | 2013-08-05 | PM | Philip Morris International Inc. | Mackay Graham | Director | Cigarettes | BUY | $89.15 | 123,500 | $11,010,408 | 137,818 | +862.6% |
| 2013-08-06 15:54 | 2013-08-02 | GUID | N/A | RGM Capital, LLC | 10% owner | Other | BUY | $7.76 | 204,782 | $1,589,661 | 3,802,835 | +5.7% |
| 2013-08-06 22:37 | 2012-10-09 | AMEH | Astrana Health, Inc. | Augusta Gary | Director | Services-Management Consulting Services | BUY | $50.00 | 50,000 | $2,500,000 | 1,666,000 | +3.1% |
| 2013-08-06 22:33 | 2012-09-01 | AMEH | Astrana Health, Inc. | Augusta Gary | Director | Services-Management Consulting Services | BUY | $100.00 | 100,000 | $10,000,000 | 1,616,000 | +6.6% |
| 2013-08-06 22:31 | 2012-08-01 | AMEH | Astrana Health, Inc. | Augusta Gary | Director | Services-Management Consulting Services | BUY | $100.00 | 100,000 | $10,000,000 | 1,516,000 | +7.1% |
| 2013-08-06 22:24 | 2012-07-01 | AMEH | Astrana Health, Inc. | Augusta Gary | Director | Services-Management Consulting Services | BUY | $100.00 | 100,000 | $10,000,000 | 1,416,000 | +7.6% |
| 2013-08-06 22:19 | 2012-06-01 | AMEH | Astrana Health, Inc. | Augusta Gary | Director | Services-Management Consulting Services | BUY | $100.00 | 100,000 | $10,000,000 | 1,316,000 | +8.2% |
| 2013-08-06 22:12 | 2012-05-01 | AMEH | Astrana Health, Inc. | Augusta Gary | Director | Services-Management Consulting Services | BUY | $100.00 | 100,000 | $10,000,000 | 1,216,000 | +9.0% |
| 2013-08-06 22:07 | 2012-04-01 | AMEH | Astrana Health, Inc. | Augusta Gary | Director | Services-Management Consulting Services | BUY | $100.00 | 100,000 | $10,000,000 | 10,116,000 | +1.0% |
| 2013-08-06 22:03 | 2012-03-01 | AMEH | Astrana Health, Inc. | Augusta Gary | Director | Services-Management Consulting Services | BUY | $340.00 | 500,000 | $170,000,000 | 1,016,000 | +96.9% |
| 2013-08-06 23:00 | 2012-01-01 | AMEH | Astrana Health, Inc. | NIHALANI SURESH | Director | Services-Management Consulting Services | BUY | $400.00 | 400,000 | $160,000,000 | 800,000 | +100.0% |
| 2013-08-06 02:29 | 2013-08-01 | ACW | N/A | Coliseum Capital Management, LLC | 10% owner | Other | BUY | $5.00 | 250,000 | $1,250,000 | 5,226,194 | +5.0% |
| 2013-08-06 01:03 | 2013-08-01 | DELL | N/A | ICAHN CARL C | Other | Other | BUY | $12.94 | 4,000,000 | $51,760,000 | 156,478,650 | +2.6% |
| 2013-08-06 00:28 | 2013-08-01 | FCX | FREEPORT-MCMORAN INC | FORD GERALD J | Director | Metal Mining | BUY | $29.18 | 1,000,000 | $29,175,500 | 1,000,000 | +100.0% |
| 2013-08-06 03:58 | 2013-08-01 | S | N/A | SOFTBANK CORP | 10% owner | Other | BUY | $6.50 | 28,808,212 | $187,345,564 | 3,105,333,735 | +0.9% |
| 2013-08-03 00:31 | 2013-07-31 | EQS | EQUUS TOTAL RETURN, INC. | des Pallieres Bertrand | Director, 10% owner | Other | BUY | $2.40 | 1,005,636 | $2,413,526 | 3,026,000 | +49.8% |
| 2013-08-03 01:29 | 2013-08-01 | SFM | Sprouts Farmers Market, Inc. | Fortunato Joe | Director | Retail-Grocery Stores | BUY | $18.00 | 62,500 | $1,125,000 | 62,500 | +100.0% |
| 2013-08-03 01:08 | 2013-07-31 | LYB | LyondellBasell Industries N.V. | AI INTERNATIONAL CHEMICALS S.A.R.L. | 10% owner | Industrial Organic Chemicals | BUY | $67.71 | 8,500,000 | $575,535,000 | 88,613 | +100.0% |
| 2013-08-03 01:47 | 2013-07-31 | N/A | N/A | Project Viking, LLC | 10% owner | Other | BUY | $0.30 | 23,075,000 | $6,922,500 | 15,000,000 | +100.0% |
| 2013-08-02 23:07 | 2013-07-31 | N/A | N/A | Fagen Diane Kathleen | 10% owner | Other | BUY | $0.30 | 23,075,000 | $6,922,500 | 17,080,949 | +100.0% |
| 2013-08-02 23:07 | 2013-07-31 | N/A | N/A | Fagen Roland J | 10% owner | Other | BUY | $0.30 | 23,075,000 | $6,922,500 | 17,080,949 | +100.0% |
| 2013-08-03 01:30 | 2013-08-01 | SFM | Sprouts Farmers Market, Inc. | GOLLEHER GEORGE | Director | Retail-Grocery Stores | BUY | $18.00 | 225,000 | $4,050,000 | 225,000 | +100.0% |
| 2013-08-02 23:00 | 2013-08-01 | BCRX | BIOCRYST PHARMACEUTICALS INC | BAKER FELIX | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $4.40 | 1,136,364 | $5,000,002 | 145,533 | +100.0% |
| 2013-08-03 00:03 | 2013-08-01 | PMCS | N/A | RELATIONAL INVESTORS LLC | 10% owner | Other | BUY | $6.60 | 324,436 | $2,141,278 | 20,845,365 | +1.6% |
| 2013-08-02 20:27 | 2013-08-01 | ACCL | N/A | RGM Capital, LLC | 10% owner | Other | BUY | $9.08 | 128,350 | $1,165,944 | 6,237,172 | +2.1% |
| 2013-08-01 18:30 | 2013-06-19 | CEMP | N/A | Quaker BioVentures II LP | 10% owner | Other | BUY | $7.00 | 265,000 | $1,855,000 | 3,527,154 | +8.1% |
| 2013-08-02 02:18 | 2013-07-30 | CNAT | N/A | Perret Marc Olivier | Director, 10% owner | Other | BUY | $11.00 | 165,525 | $1,820,775 | 1,487,320 | +12.5% |
| 2013-08-02 02:16 | 2013-07-30 | CNAT | N/A | KLINGENSTEIN PAUL H | Director, 10% owner | Other | BUY | $11.00 | 107,422 | $1,181,642 | 52,419 | +100.0% |
| 2013-08-02 02:10 | 2013-07-30 | CNAT | N/A | COOPERATIVE GILDE HEALTHCARE II U.A. | 10% owner | Other | BUY | $11.00 | 165,525 | $1,820,775 | 1,487,320 | +12.5% |
| 2013-08-02 02:14 | 2013-07-30 | CNAT | N/A | Malik Shahzad | Director, 10% owner | Other | BUY | $11.00 | 190,054 | $2,090,594 | 2,166,836 | +9.6% |
| 2013-08-01 21:18 | 2013-07-30 | CNAT | N/A | MPM BioVentures IV QP LP | 10% owner | Other | BUY | $11.00 | 165,265 | $1,817,915 | 1,192,080 | +16.1% |
| 2013-08-01 21:21 | 2013-07-30 | CNAT | N/A | Scopa James Paul | Director | Other | BUY | $11.00 | 165,265 | $1,817,915 | 1,192,080 | +16.1% |
| 2013-08-02 02:18 | 2013-07-30 | CNAT | N/A | Aberdare GP III, L.L.C. | 10% owner | Other | BUY | $11.00 | 107,422 | $1,181,642 | 52,419 | +100.0% |
| 2013-08-02 02:09 | 2013-07-30 | CNAT | N/A | ADVENT VENTURE PARTNERS LLP | 10% owner | Other | BUY | $11.00 | 190,054 | $2,090,594 | 2,166,836 | +9.6% |
| 2013-08-02 02:12 | 2013-07-30 | CNAT | N/A | LACASSE LOUIS P | Director | Other | BUY | $11.00 | 123,950 | $1,363,450 | 809,887 | +18.1% |
| 2013-08-01 18:32 | 2013-06-19 | CEMP | N/A | NEFF P SHERRILL | Director | Other | BUY | $7.00 | 265,000 | $1,855,000 | 3,527,154 | +8.1% |
| 2013-08-01 21:19 | 2013-07-30 | CNAT | N/A | EVNIN LUKE | 10% owner | Other | BUY | $11.00 | 165,265 | $1,817,915 | 1,192,080 | +16.1% |
| 2013-08-01 23:12 | 2013-07-30 | ONTX | Traws Pharma, Inc. | Michael & Jane Hoffman 2013 Descendants | 10% owner | Pharmaceutical Preparations | BUY | $15.00 | 1,000,000 | $15,000,000 | 4,287,800 | +30.4% |
| 2013-08-01 23:11 | 2013-07-30 | ONTX | Traws Pharma, Inc. | Hoffman Michael B | Director, 10% owner | Pharmaceutical Preparations | BUY | $15.00 | 1,000,000 | $15,000,000 | 4,372,330 | +29.7% |
| 2013-08-01 16:23 | 2013-07-30 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% owner | Pharmaceutical Preparations | BUY | $111,850,855.50 | 3,064,407 | $342,756,544,550,189 | 29,785,600 | +11.5% |
| 2013-08-02 03:19 | 2013-07-30 | HNSN | N/A | WEINSTEIN WILL K | Director | Other | BUY | $1.23 | 869,825 | $1,069,885 | 869,825 | +100.0% |
| 2013-08-01 23:06 | 2013-07-30 | ONTX | Traws Pharma, Inc. | Baxter Healthcare SA | 10% owner | Pharmaceutical Preparations | BUY | $15.00 | 330,000 | $4,950,000 | 2,603,295 | +14.5% |
| 2013-08-01 01:54 | 2013-07-31 | LIQD | N/A | VON ALLMEN DOUGLAS J | 10% owner | Other | BUY | $9.00 | 1,722,100 | $15,498,900 | 555,500 | +100.0% |
| 2013-08-01 00:47 | 2013-07-15 | OCRX | N/A | Domain Partners VI, L.P. | 10% owner | Other | BUY | $6.03 | 331,873 | $1,999,999 | 1,857,036 | +21.8% |
| 2013-07-31 22:18 | 2013-07-29 | YRCW | N/A | LASRY MARC | 10% owner | Other | BUY | $27.77 | 1,302,000 | $36,152,634 | 374,881 | +100.0% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.